Rationale for routine use of IORT for early breast cancer and data for specific indications

Compartir :
Published: 9 Mar 2023
Views: 406
Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Dr Hans-Christian Kolberg speaks to ecancer about the rationale for routine use of intraoperative radiotherapy (IORT) for early breast cancer and data for specific indications.

He outlines the use of IORT in clinical routine examining the background and results of a variety of clinical trials such as the TARGIT-A trial.

Dr Kolberg also presents the use of IORT in specific indications using his own data and experiences after over 1000 cases.

He concludes that in selected patients IORT can today be offered as the only radiation which does not compromise the oncological outcomes. However, the possible beneficial effect of IORT on non-breast cancer mortality requires further investigation.

ecancer's filming has been kindly supported by Zeiss. ecancer is editorially independent and there is no influence over content.